Additional Financial Information
$6.2 million cash and cash equivalents (6/30/03)
DSOs (Q2’03)*
- 38 days, gross billings basis
No long term debt, $0.7M of capital leases and other short-term financial arrangements (6/30/03)
Depreciation and amortization $367K (Q2’03)
Approximately $1.9M of operating expense related to public stock listing, mostly fixed costs unaffected by business growth
Weighted average shares outstanding of approximately 38.9M (Q2’03)
* Please refer to the reconciliation of net revenue days sales outstanding to gross billings days sales outstanding furnished in the company’s Form 8-K filed on July 24, 2003.
DSOs for Q2’03 were 57 days on a net revenue basis